Karyopharm Outlines Key Selinexor Clinical Development Achievements
- Enrollment Complete in Phase 2b STORM Clinical Trial in Multiple Myeloma - - Patient Dosing Underway in Phase 1b Clinical Trial of Selinexor in Combination with Chemotherapeutic, Targeted and Immunotherapeutic Agents - NEWTON, Mass., June 16, 2016 (GLOBE …